Several strains of mouse hepatitis virus (MHV), including the JHM and A59 strains, cause acute encephalitis and acute and chronic demyelinating diseases in mice (42). The adaptive immune response to murine coronaviruses has been partially characterized. Robust CD4 and CD8 T-cell responses to viral antigens have been detected in mice infected with most strains of MHV-JHM or MHV-A59 (34, 37, 43 ). An antivirus antibody response is also present in infected mice and is critical for preventing virus recrudescence (36). These results suggest that presentation of viral antigen to naïve T cells, a process that involves professional antigen-presenting cells such as DCs, is effective. Other studies, however, suggest that the anti-MHV CD8 T-cell response was not optimal in MHV-JHM-infected mice and was diminished compared to that observed in mice infected with the MHV-A59 strain (37). Although not examined, these effects may have resulted from suboptimal DC function.
Several strains of mouse hepatitis virus (MHV), including the JHM and A59 strains, cause acute encephalitis and acute and chronic demyelinating diseases in mice (42) . The adaptive immune response to murine coronaviruses has been partially characterized. Robust CD4 and CD8 T-cell responses to viral antigens have been detected in mice infected with most strains of MHV-JHM or MHV-A59 (34, 37, 43 ). An antivirus antibody response is also present in infected mice and is critical for preventing virus recrudescence (36) . These results suggest that presentation of viral antigen to naïve T cells, a process that involves professional antigen-presenting cells such as DCs, is effective. Other studies, however, suggest that the anti-MHV CD8 T-cell response was not optimal in MHV-JHM-infected mice and was diminished compared to that observed in mice infected with the MHV-A59 strain (37) . Although not examined, these effects may have resulted from suboptimal DC function.
DCs are critical in the host immune response to viral pathogens. DCs include several subsets based on phenotypic markers (CD11b, CD8, B220, Ly-6C). CD8
ϩ DCs are considered most important for T-cell cross-priming (8), whereas plasmacytoid DCs express large amounts of alpha/beta interferons (IFN-␣/␤) in response to viral infections (reviewed in reference 6). Viruses have developed strategies to depress the function of these cells. Some viruses impair DC function in vitro (2, 22, 26, 31) , but only a few studies have examined the effect of viral infection in vivo. Certain immunosuppressive strains of lymphocytic choriomeningitis virus (LCMV) infect DCs in vivo, resulting, ultimately, in the loss of normal splenic architecture and in LCMV-specific CD8 T-cell exhaustion (12, 39) . The immunosuppressive effect of LCMV involves, in part, the IFN-␣/␤-dependent suppression of DC expansion and maturation; measles virus activates the same pathway to inhibit DC maturation and proliferation in vivo (13) . In an elegant set of studies, Andrews and colleagues showed that murine cytomegalovirus infected DCs in vivo and in vitro, resulting in the impaired upregulation of costimulatory molecules and diminished antigen processing. These defects, in turn, resulted in decreased ability to activate naïve T cells (1) . While this effect on DC function was transient in infected mice, it most likely facilitated murine cytomegalovirus persistence.
Little is known about DC function in vivo after infection with MHV. Dendritic cells are readily infected by MHV-A59 and form syncytia in vitro (45) . The primary host cell receptor for MHV is CEACAM-1a, a member of the carcinoembryonic antigen family (15) . CEACAM-1a is expressed on DCs (20) , and infection of DCs in vitro is CEACAM-1a dependent (45) . After syncytium formation, DCs are unlikely to function normally. Development of the anti-MHV immune response would be compromised if large numbers of DCs were similarly infected in mice. Infection with virulent strains of MHV-JHM may have a more profound effect on the innate and adaptive immune responses than MHV-A59 (37) . Also, there is an apparent contradiction between the relative ease with which DCs are infected in vitro and the robustness of the T-cell response in vivo. For both of these reasons, we assessed the extent to which DCs are infected by MHV-JHM after culture and in mice. We also extended these analyses to mature and immature populations of DCs.
MATERIALS AND METHODS
Mice. Specific-pathogen-free 5-to 8-week-old C57BL/6 (B6) mice (National Cancer Institute, Bethesda, MD) were used in most studies. Mice were inoculated intranasally with 6 ϫ 10 4 PFU or intraperitoneally with 0.5 ϫ 10 6 to 1.0 ϫ 10 6 PFU of virus. P14 mice, transgenic for a T-cell receptor that recognizes the gp33 peptide from the LCMV glycoprotein, were provided by J. Harty (University of Iowa, Iowa City, IA).
(SA-APC; Molecular Probes) or SA-PerCP (BD Pharmingen). Samples were analyzed on a Becton Dickinson LSR II or FACScan flow cytometer (BD Biosciences, Mountain View, CA). CD11c ϩ CD86 hi and CD11c ϩ CD86 lo cells were sorted using a DIVA flow cytometer (BD Biosciences).
T-cell proliferation assay. BM-derived DCs were either mock infected or infected with MHV-JHM (MOI of 100) for 0, 2, 5, or 8 h before pulsing with 1 M gp33 peptide for 1 h. Cells were harvested and washed with medium two times to remove soluble peptide. CD8 ϩ T cells were isolated by negative selection from the spleens of P14-Tg mice by using magnetic beads (Miltenyi Biotec). CFSE (5-and 6-carboxyfluorescein diacetate succinimidyl ester, 10 M; Molecular Probes)-labeled P14-Tg CD8 ϩ T cells were then cocultured with the peptide-pulsed DCs at a DC/T-cell ratio of 1:100 or 1:500 at 37°C for 3 days in 96-well plates. Proliferation of T cells was then measured by flow cytometry. The division index is the average number of divisions calculated from the FACS data.
In some experiments, T-cell apoptosis was assayed as described below.
Growth of MHV-JHM in cells treated with protease inhibitors. L929 cells or BM-derived DCs were preincubated for 4 h in medium that contained 0 to 100 M CA074 (Sigma) or 0 to 10 M FYdmk [Z-Phe-Tyr(t-Bu)-diazomethyl ketone; Calbiochem, La Jolla, CA]. The medium was removed, and cells were infected with MHV-JHM at an MOI of 1. After 30 min of incubation, cells were washed twice with PBS and then cultured with fresh medium supplemented with CA074 or FYdmk for 20 h. Viruses were titered on HeLa-MHVR cells by plaque assay.
Apoptosis assay. rJHM.GFP-infected, BM-derived DCs were harvested at 9 h p.i. and stained with PE-conjugated anti-CD11c and biotinylated annexin V (BD Pharmingen), followed by propidium iodide (PI; BD Pharmingen) and SA-APC staining. In other experiments, MHV-JHM-infected DCs were stained with PEconjugated anti-CD11c, biotinylated annexin V, and FITC-conjugated anti-CD86 MAbs, followed by SA-APC.
IFN bioassay. Levels of IFN were measured using a bioassay based on the inhibition of vesicular stomatitis virus (VSV) growth in L929 cells. DCs were infected with MHV-JHM at an MOI of 1. Supernatants were harvested, and MHV-JHM was UV inactivated. L929 cells infected with 1,000 PFU VSV were treated with dilutions of supernatants or recombinant murine IFN-␤ (PBL Biomedical Laboratories, Piscataway, NJ) at 30 min p.i. Titers of VSV were determined on Vero cells. IFN levels were calculated based on the standard curves generated with recombinant IFN-␤. To verify production of IFN by DCs, samples were treated with 25 g/ml poly(I · C) (Invivogen, San Diego, CA) or 1 g/ml lipopolysaccharide (LPS; Sigma, St. Louis, MO) and supernatants were assayed.
Sensitivity to IFN-␤. The relative sensitivity of MHV-JHM to IFN-␤ was measured by treating DCs with serial dilutions of IFN-␤ for 24 h prior to infection with MHV-JHM. After infection, the same concentrations of IFN-␤ were added to the culture. In some experiments, infected DCs were treated only with serial dilutions of IFN-␤ 30 min after infection. MHV was titered on HeLa-MHVR cells. As a control, VSV-infected L929 cells were treated with IFN-␤ and virus titered on Vero cells.
RESULTS

MHV-JHM productively infects DCs.
Initial experiments were directed at examining the ability of MHV-JHM to infect DCs after in vitro culture. For this purpose, we cultured DCs from murine BM as previously described (14, 18) . Culture in the presence of interleukin-4/granulocyte-macrophage colonystimulating factor results in the preferential outgrowth of myeloid DCs (CD11b ϩ CD11c ϩ ). After infection with MHV-JHM (MOI of 1), viral antigen was detected in infected, but not uninfected, cells by 7 h p.i. Virus-induced syncytium formation was apparent by 7 to 9 h p.i. Many, but not all, of the infected cells expressed the DC marker CD11c (Fig. 1A) . To confirm that CD11c ϩ cells were directly infected by the virus and not merely incorporated into syncytia initiated by other infected cells in the culture, we selected CD11c ϩ cells by using magnetic beads prior to MHV-JHM infection. These cells were also infected by MHV-JHM ( productive with newly produced infectious virus detected as early as 8 h p.i. (Fig. 1D ). Virus titers were maximal at 24 h p.i.
MHV-JHM preferentially infects CD86 hi and MHC class I/II
hi mature DCs. Immature DCs phagocytose antigen and migrate to lymphoid organs. After maturation, as evidenced by costimulatory molecule and major histocompatibility complex (MHC) class I/II antigen upregulation, DCs are able to present antigen to naïve T cells. To determine whether mature or immature DCs were preferentially infected with MHV-JHM, we infected unfractionated BM-derived DCs with MHV-JHM and analyzed cells by FACS analysis. To simplify analyses, we developed a recombinant MHV-JHM virus that expressed GFP (rJHM.GFP), as described in Materials and Methods (Fig. 1C) . GFP was introduced into gene 4 by using targeted recombination, since we and others have shown that the gene 4 protein is not essential for viral growth in tissue culture cells or for the induction of acute encephalitis (30, 49) . rJHM.GFP replicates with slower kinetics in tissue culture cells but causes acute encephalitis with approximately the same kinetics as nonrecombinant MHV-JHM ( Fig. 1D and data not shown). This difference in the in vitro growth kinetics was reported previously for all recombinant MHV-JHM and does not specifically reflect the presence of GFP (30) . After 10 passages of rJHM.GFP in vitro, more than 90% of infected cells still expressed GFP. Also, after intranasal inoculation of B6 mice, nearly all infected cells in the brain, as detected by N protein expression, were GFP ϩ (Fig. 1E) . Similar results were obtained when virus harvested from the central nervous system was grown in tissue culture cells and assayed for GFP expression (data not shown).
When DCs were infected with this virus and stained for CD11c, MHC class I/II, and CD86, the majority of infected CD11c ϩ cells were MHC class I/II hi and CD86 hi , consistent with a mature phenotype (Fig. 2 ). Cells were analyzed at 9 h p.i. to maximize the detection of infected cells but minimize the percentage of cells in syncytia; syncytia are not easily detectable by cell sorter analysis. These results also suggested that MHV-JHM infection does not result in the downregulation of costimulatory molecules, as occurs in other viral infec- To distinguish between these possibilities, we separated CD86 hi and CD86 lo DCs by flow cytometric sorting prior to infection with rJHM.GFP. As shown for rJHM.GFP-infected cells at 9 h p.i., CD86 hi cells were preferentially infected by the virus (Fig. 3A) . In these analyses, cells were infected at an MOI of 10, and the fraction of CD86 hi cells that were GFP ϩ was at least 10 times higher than that of CD86 lo cells. However, even by 9 h p.i., some syncytia were present in both populations. To eliminate the possibility that infected immature DCs preferentially formed syncytia and were therefore excluded from the FACS analysis, we quantified the proportion of GFP ϩ cells by fluorescence microscopy. Again, the percentage of GFP ϩ cells was more than 10 times higher in CD86 hi (32.6% Ϯ 3.7%) than in CD86 lo (2.1% Ϯ 1.5%) DCs after infection at an MOI of 10. Infection of both cell types was productive, although only low levels of infectious virus were released from CD86 lo cells (Fig. 3B) . Virus titers diminished at later times p.i. in the CD86 hi cultures, probably as a consequence of virusmediated cell death.
Of note, rA59.GFP also preferentially infects mature DCs (Fig. 3A) . Both viruses also infect CD11c
Ϫ cells within the dendritic cell culture, but rA59.GFP infects a higher percentage of these cells than does rJHM.GFP (Fig. 3A) . DC function is impaired after infection. While cells in syncytia are unlikely to present antigen efficiently, it is possible that MHV-JHM infection decreases antigen presentation by DCs even at early times p.i. To examine this possibility, MHV-JHM-infected BM-derived DCs were pulsed with gp33 peptide and incubated for 3 days with CFSE-labeled P14-Tg CD8 T cells at a DC/T-cell ratio of 1:100 or 1:500. In these assays, only a short period of exposure of T cells to DCs is required for their maximal proliferation (46) . Mock-infected DCs stimulated P14-Tg CD8 T cells to proliferate (Fig. 4A) . However, even by 3 h p.i., DCs in infected cultures were impaired in their ability to prime naïve T cells. Both the percentage of divided cells and the division index were decreased by 25 to 40% at 3 h p.i. This effect was more noticeable by 6 h, although only a few syncytia were observed in the cultures at this time. This lack of proliferation of T cells was not a consequence of the induction of apoptosis or cell death by the infected DCs because we detected no increases in annexin V or PI staining in the cocultured T cells (Fig. 4B) . Another possibility is that T cells, known to upregulate CEACAM-1a expression after activation (28) , become infected in the cocultures. However, we detected no GFP ϩ T cells when P14-Tg T cells were incubated with rJHM.GFP-infected DCs or when naïve T cells were activated with phorbol 12-myristate 13-acetate and ionomycin prior to infection with rJHM.GFP (data not shown).
Preferential infection of CD86 hi cells does not correlate with higher levels of CEACAM-1a surface expression or increased apoptosis. One explanation for the difference in infection rate between mature and immature DCs is that CEACAM-1a, the MHV receptor, is expressed at higher levels on CD86 hi cells. To assess surface levels of CEACAM-1a, we incubated unfractionated CD11c
ϩ DCs with anti-CEACAM-1a MAb. As shown in Fig. 5 , similar levels of CEACAM-1a were expressed on CD86 hi and CD86 lo cells after flow cytometric analysis. These results agree with a previous report showing that CEACAM-1a surface expression was not increased after DC maturation (20) .
Another possible explanation for the observed difference was that MHV-JHM preferentially induced apoptosis in CD86 lo cells, thereby inhibiting virus replication prior to GFP expression. MHV has been shown to induce apoptosis in infected fibroblasts, although signs of apoptosis were not detected until 16 to 20 h p.i. (5) . However, we observed that only a small percentage of infected or uninfected cells in rJHM. GFP-infected DC cultures were apoptotic (annexin V ϩ PI Ϫ ) (Fig. 6A ). In addition, there was no difference in the proportion of CD86 hi or CD86 lo cells that underwent apoptosis when MHV-JHM-infected and uninfected cultures were compared at 9 h p.i. (Fig. 6B) .
Viral growth is not affected by treatment with cathepsin B and cathepsin L inhibitors. Entry of severe acute respiratory syndrome coronavirus (SARS-CoV) was recently shown to require exposure to cathepsin L in the endosomes (41) . Furthermore, cathepsin L is upregulated in DCs upon maturation (44) . Therefore, to determine if this upregulated expression of cathepsin L in mature DCs contributed to their increased susceptibility to MHV-JHM, we treated cells with FYdmk, an inhibitor of cathepsin L (40) . Initially, we treated L929 cells with the inhibitor at a range of concentrations, 0 to 10 M. (Fig. 7) . Cathepsin B is required for Ebola virus entry (4). We observed no effect on MHV-JHM growth in L929 cells after treatment with CA074 (27), a specific cathepsin B inhibitor (data not shown).
Infection of DCs in vivo and directly ex vivo.
These results show that MHV-JHM readily infects DCs in vitro and causes syncytium formation, but nothing is known about the infection of DCs in animals by any strain of MHV. To determine the extent of infection of DCs in vivo, we inoculated mice intraperitoneally with 0.5 ϫ 10 6 to 1. p.i. These results are not due to a loss of GFP expression after passage in vivo because GFP was readily detected in nearly all infected cells in the brain after intranasal inoculation (Fig. 1E) . It is possible that DCs are infected in vivo but that infected cells are rapidly cleared. To address this possibility, we infected splenic DCs harvested from naïve mice directly ex vivo. Initially, unfractionated splenic cells were infected with rJHM. GFP and analyzed by FACS analysis at 9 h p.i. Approximately 1 to 2% of CD11c ϩ cells were GFP ϩ (data not shown), as were 1% of B220 ϩ CD11c Ϫ B cells (Fig. 8A) . B cells express high levels of the MHV receptor CEACAM-1a, but others have previously shown that they are not readily infected by MHV (25) . DCs comprise less than 1% of splenocytes, making FACS analyses of DC subpopulations within unfractionated spleen populations difficult. Therefore, we selected CD11c ϩ cells by magnetic bead sorting and infected them with rJHM.GFP at an Approximately 2 to 5% of total DCs were infected by the virus. Cells were also stained for CD8 and CD11b expression. As shown in Fig. 8C , both cell populations (CD8 ϩ CD11b Ϫ CD11c ϩ and CD8 Ϫ CD11b ϩ CD11c ϩ ) could be infected by rJHM.GFP. Of note, both subsets express CEACAM-1a at equivalent levels (Fig. 8B) .
MHV-JHM does not induce interferon production in DCs and is modestly sensitive to IFN treatment. A key function of both plasmacytoid DCs and myeloid DCs is to produce IFN-␣/␤ (9). MHV-infected fibroblasts do not express significant amounts of IFN and are only modestly sensitive to IFN-␤ treatment (11, 33) . Consistent with these results, infection with MHV-JHM did not induce interferon production by DCs (Ͻ1 U) at 9 h or even at 20 h p.i., when more than 50% of the cells in the DC culture were infected and formed syncytia. In contrast, treatment with poly(I · C) or LPS for 20 h induced significant amounts of IFN [with poly(I · C), 148.6 Ϯ 20.0 U; with LPS, 20.3 Ϯ 0.7 U]. Replication of MHV-JHM in DCs was diminished only modestly when DCs were treated with murine IFN-␤ prior to and after infection, even after exposure to high doses. Even less inhibition was observed when cells were posttreated with IFN-␤ (Fig. 9) . Thus, as in fibroblasts, MHV-JHM replication in DCs is only moderately inhibited by IFN-␤ treatment.
DISCUSSION
Our results show that MHV-JHM infects cultured BM-derived DCs, with extensive syncytium formation, but that DC infection in vivo is not easily detectable. Part of the explanation for this disparity between in vivo and in vitro infection is that MHV-JHM has a propensity to infect mature DCs whereas the vast majority of DCs in naïve or infected animals are immature. This results in a small percentage of the total DC population that is susceptible to infection with MHV-JHM. Other viruses also preferentially infect mature DCs. For example, mature blood-derived human DCs are infected at a higher level by respiratory syncytial virus than are immature cells (2) . Although human cytomegalovirus preferentially infects immature blood-borne DCs, other results show that the virus also has a tropism for mature Langerhans cells (16) . Some viruses infect mature DCs and downregulate surface expression of MHC class II and costimulatory molecules, thereby impairing T-cell activation (26) . However, we did not observe downregulation of these molecules on MHV-JHM-infected cells (Fig. 2) .
Our results suggest that MHV-JHM replicates more efficiently in mature DCs than in immature cells. The MHV receptor CEACAM-1a is expressed at equivalent levels on mature and immature DCs, suggesting that this difference does not occur at the level of initial binding to cells (Fig. 5) . While MHV-A59, like MHV-JHM, preferentially infected mature DCs, we observed that CD11c
Ϫ cells, which serve as precursors to DCs in these cultures, were 5 to 10 times more susceptible to MHV-A59 infection than MHV-JHM (Fig. 3A) . This may occur because MHV-JHM appears to require a second host factor for the efficient infection of some cells. In previous studies, a difference in the ability of MHV-JHM and MHV-A59 to infect a set of cell lines derived from susceptible mice was observed, with MHV-JHM infecting some of these cells very inefficiently (48) . Of note, MHV-JHM or MHV-A59 infection of even mature DCs is not very efficient in vitro, with only 70% of mature DCs infected by MHV-JHM at an MOI of 100 (data not shown).
While a second factor required for MHV-JHM infection of cells has not been identified, it is noteworthy that infection of cells by SARS-CoV is facilitated by the presence of one or more molecules in addition to angiotensin-converting enzyme 2, the primary receptor for the virus (23) . In the case of SARSCoV, the presence of either DC-SIGN or DC-SIGNR may enhance virus binding and subsequent entry (19, 24) . As discussed above, recent data show that an endosomal (acid-pHdependent) protease, cathepsin L, is required for the fusion of SARS-CoV (41). MHV-JHM fusion with the host cell membrane may also require a similar protease, and this might contribute to preferential infection of mature DCs. Our results show that cathepsins L and B are unlikely to be the proteases involved in MHV-JHM fusion. This may not be surprising because MHV-JHM, unlike SARS-CoV, undergoes a pH-independent fusion reaction to deliver infectious viral RNA into the cells (10) .
Our results suggest a mechanism by which MHV-JHM may delay the onset of the immune response. Even 3 h after infection, exposure to MHV-JHM significantly reduced DCs' ability to stimulate the proliferation of antigen-specific CD8 T cells (Fig. 4A) . Previous work showed that naïve T cells were nearly completely activated by as short an exposure as 2 h to peptidelabeled antigen-presenting cells (46) . MHV-JHM did not induce syncytium formation or cell death in infected DCs until 6 to 7 h p.i., suggesting that a decrease in viable cell number did not account for the observation that DCs functioned suboptimally at 3 h p.i. We could not detect any MHV-JHM-induced downregulation of the costimulatory molecule CD86 or of MHC class I/II expression after infection (Fig. 2) . This lack of downregulation of CD86 was also observed in purified cultures of CD86
hi DCs after MHV-JHM infection (data not shown). Thus, the precise mechanism of MHV-JHM inhibition of DC function at early times p.i. remains to be investigated. In terms of other components of the innate immune response, MHV-JHM did not induce IFN production, and virus replication was only modestly sensitive to IFN treatment in fibroblasts (11, 33) or DCs (Fig. 9) . The lack of IFN-␣/␤ production that we observed may also contribute to the relatively small amount of DC maturation that occurred in infected cultures (Fig. 2) . Many RNA viruses, such as dengue virus, respiratory syncytial virus, measles, and parainfluenza virus type 3, induce maturation after in vitro infection of blood-derived human DCs or BM-derived murine DCs in a process that often involves IFN (2, 3, 13, 17, 35, 38) .
Collectively, our results suggest that MHV-JHM hampers the initiation of the innate and adaptive antiviral immune responses by infecting mature DCs and inhibiting IFN production from these cells. Future work will be directed at determining the mechanism of the differential infection of mature and immature DCs.
